Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 75% confidence The document is a company press release announcing the award of a public tender contract. It provides operational details about a commercial contract and contains no financial statements, earnings figures, management changes, or regulatory compliance filing. It does not fit any specific category such as Earnings Release, Financing Update, M&A, or Share Issuance. It is a general corporate announcement and thus falls into the fallback category of Regulatory Filings (RNS).
2026-05-19 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing the award of a public procurement contract, not a financial report, dividend notice, management change, or similar specific filing. It does not present financial statements or regulatory certifications but is a general corporate announcement. Therefore it falls into the fallback category of Regulatory Filings.
2026-05-19 French
Inside Information / Other news releases
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing a strategic Memorandum of Understanding and a first commercial customer agreement. It contains no detailed financial statements, no dividend or share issuance details, no governance, no M&A offer, no audit findings, and no call transcript. It is a general corporate update/announcement. Such press releases are classified under Regulatory Filings (RNS) as a fallback for announcements that do not match other specific categories.
2026-05-11 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 40% confidence The document is a press release announcing a strategic Memorandum of Understanding and first commercial customer. It contains no financial statements, no board or management changes, no dividend, no share issuance, no M&A transaction documentation, and is not a report itself. It is a general corporate announcement. Under the taxonomy, such miscellaneous press releases fall under Regulatory Filings (RNS) as the fallback category for announcements not covered by more specific codes.
2026-05-11 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic distribution agreement between Hospitex International (a subsidiary of Aliko Scientific) and Naturneed. It details the commercial partnership, product information, and strategic goals. As it is a general corporate announcement regarding business operations and does not fit into specific categories like M&A (which usually implies a merger or acquisition of a company), financial reporting, or shareholder-specific filings, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2026-03-10 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release issued by Aliko Scientific (Ikonisys SA) announcing a strategic distribution agreement for their product 'Urine24'. It details the partnership, commercial targets, and the company's expansion strategy. Since it does not fit into specific categories like financial reports, board changes, or legal proceedings, and is a general corporate announcement regarding business operations, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2026-03-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.